$ISCO
International Stem Cell CORP

2013 Q4 Form 10-Q Financial Statement

#000119312513439222 Filed on November 13, 2013

View on sec.gov

Income Statement

Concept 2013 Q4 2013 Q3 2012 Q3
Revenue $1.740M $1.670M $1.187M
YoY Change 39.2% 40.69% 41.31%
Cost Of Revenue $530.0K $447.0K $320.0K
YoY Change 65.63% 39.69% -11.11%
Gross Profit $1.200M $1.223M $867.0K
YoY Change 29.03% 41.06% 80.63%
Gross Profit Margin 68.97% 73.23% 73.04%
Selling, General & Admin $2.210M $1.994M $2.047M
YoY Change -15.97% -2.59% -17.13%
% of Gross Profit 184.17% 163.04% 236.1%
Research & Development $920.0K $932.0K $900.0K
YoY Change 2.22% 3.56% -20.35%
% of Gross Profit 76.67% 76.21% 103.81%
Depreciation & Amortization $110.0K $100.0K $106.0K
YoY Change 10.0% -5.66% -18.46%
% of Gross Profit 9.17% 8.18% 12.23%
Operating Expenses $3.140M $2.926M $2.947M
YoY Change -10.8% -0.71% -18.14%
Operating Profit -$1.940M -$1.703M -$2.080M
YoY Change -25.1% -18.13% -33.33%
Interest Expense -$780.0K $30.00K $0.00
YoY Change -100.0%
% of Operating Profit
Other Income/Expense, Net -$50.00K -$2.096M -$1.000K
YoY Change 400.0% 209500.0%
Pretax Income -$2.770M -$3.799M -$2.081M
YoY Change 6.54% 82.56% -18.71%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$2.770M -$3.799M -$2.081M
YoY Change 6.54% 82.56% -18.71%
Net Earnings / Revenue -159.2% -227.49% -175.32%
Basic Earnings Per Share
Diluted Earnings Per Share -$2.798M -$4.471M -$3.586M
COMMON SHARES
Basic Shares Outstanding 149.2M shares 132.6M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2013 Q4 2013 Q3 2012 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $2.240M $1.790M $2.380M
YoY Change 244.62% -24.79% -7.75%
Cash & Equivalents $2.243M $1.792M $2.380M
Short-Term Investments
Other Short-Term Assets $710.0K $460.0K $290.0K
YoY Change 54.35% 58.62% 3.57%
Inventory $1.369M $1.360M $1.120M
Prepaid Expenses
Receivables $306.0K $398.0K $410.0K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $4.626M $4.007M $4.210M
YoY Change 79.16% -4.82% -8.68%
LONG-TERM ASSETS
Property, Plant & Equipment $830.0K $851.0K $1.240M
YoY Change -26.81% -31.37% -18.42%
Goodwill
YoY Change
Intangibles $2.250M $2.036M
YoY Change 37.7%
Long-Term Investments
YoY Change
Other Assets $30.00K $30.00K $20.00K
YoY Change 50.0% 50.0% 0.0%
Total Long-Term Assets $3.113M $2.920M $2.910M
YoY Change 11.66% 0.34% 7.38%
TOTAL ASSETS
Total Short-Term Assets $4.626M $4.007M $4.210M
Total Long-Term Assets $3.113M $2.920M $2.910M
Total Assets $7.739M $6.927M $7.120M
YoY Change 44.12% -2.71% -2.73%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $532.0K $522.0K $1.060M
YoY Change -45.1% -50.75% 70.97%
Accrued Expenses $1.290M $1.056M $470.0K
YoY Change 76.71% 124.68% -29.85%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $250.0K
YoY Change -100.0% 0.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $7.021M $6.389M $1.960M
YoY Change 221.03% 225.97% -10.5%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $7.021M $6.389M $1.960M
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $7.020M $6.390M $1.960M
YoY Change 220.55% 226.02% -10.5%
SHAREHOLDERS EQUITY
Retained Earnings -$82.27M -$79.50M
YoY Change 14.6%
Common Stock $151.0K $134.0K
YoY Change 73.56%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$4.223M -$4.403M $5.150M
YoY Change
Total Liabilities & Shareholders Equity $7.739M $6.927M $7.120M
YoY Change 44.12% -2.71% -2.73%

Cashflow Statement

Concept 2013 Q4 2013 Q3 2012 Q3
OPERATING ACTIVITIES
Net Income -$2.770M -$3.799M -$2.081M
YoY Change 6.54% 82.56% -18.71%
Depreciation, Depletion And Amortization $110.0K $100.0K $106.0K
YoY Change 10.0% -5.66% -18.46%
Cash From Operating Activities -$1.410M -$1.340M -$1.660M
YoY Change -10.19% -19.28% -35.16%
INVESTING ACTIVITIES
Capital Expenditures -$390.0K -$140.0K -$180.0K
YoY Change 160.0% -22.22% -37.93%
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00 $0.00
YoY Change
Cash From Investing Activities -$390.0K -$140.0K -$180.0K
YoY Change 143.75% -22.22% -37.93%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $2.377M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 2.230M 2.620M -70.00K
YoY Change -3842.86% -103.76%
NET CHANGE
Cash From Operating Activities -1.410M -1.340M -1.660M
Cash From Investing Activities -390.0K -140.0K -180.0K
Cash From Financing Activities 2.230M 2.620M -70.00K
Net Change In Cash 430.0K 1.140M -1.910M
YoY Change -124.86% -159.69% 92.93%
FREE CASH FLOW
Cash From Operating Activities -$1.410M -$1.340M -$1.660M
Capital Expenditures -$390.0K -$140.0K -$180.0K
Free Cash Flow -$1.020M -$1.200M -$1.480M
YoY Change -28.17% -18.92% -34.8%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2006Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000 shares
CY2006Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2006Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2006Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2012Q3 isco Net Revenue Derived From Referral Sales Percent
NetRevenueDerivedFromReferralSalesPercent
0.09 pure
CY2013Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
149224387 shares
CY2013Q1 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
2500000 shares
CY2013Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
5000000 shares
CY2013Q1 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights
0.20
CY2013Q1 us-gaap Common Stock Value
CommonStockValue
1000000
CY2013Q1 isco Percentage Of Shares Purchased After Exercising Warrants
PercentageOfSharesPurchasedAfterExercisingWarrants
0.50 pure
CY2006Q3 isco Warrants In Subsidiary Company
WarrantsInSubsidiaryCompany
20000000 shares
CY2008Q2 isco Advances
Advances
250000
CY2008Q2 isco Specified Amount Of Revenue To Be Utilized First For Advances
SpecifiedAmountOfRevenueToBeUtilizedFirstForAdvances
250000
CY2012Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000 shares
CY2013Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2013Q3 isco Warrant Liabilities
WarrantLiabilities
4500000
CY2001Q3 us-gaap Stockholders Equity
StockholdersEquity
CY2012Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2380000
CY2012Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
4400000
CY2012Q3 isco Liabilities Associated With Warrants
LiabilitiesAssociatedWithWarrants
0
CY2013Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
134169565 shares
CY2013Q3 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
23694693 shares
CY2013Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
134169565 shares
CY2013Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
5780175 shares
CY2013Q3 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
147022156 shares
CY2013Q3 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1
0.96
CY2013Q3 us-gaap Share Price
SharePrice
0.15
CY2012Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2012Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
730000
CY2012Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1340000
CY2012Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
69945000
CY2013Q3 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1
0.96
CY2013Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
48429166 shares
CY2013Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
17914518 shares
CY2013Q3 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
17914518 shares
CY2013Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000 shares
CY2013Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2013Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
0.15
CY2013Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1056000
CY2013Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1626000
CY2013Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
74967000
CY2013Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
522000
CY2013Q3 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
19000
CY2013Q3 us-gaap Liabilities Current
LiabilitiesCurrent
6389000
CY2013Q3 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
4389000
CY2013Q3 us-gaap Stockholders Equity
StockholdersEquity
-4403000
CY2013Q3 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
16000
CY2013Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-79504000
CY2013Q3 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
156000
CY2013Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
495000
CY2013Q3 us-gaap Common Stock Value
CommonStockValue
134000
CY2013Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
6927000
CY2013Q3 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
77000
CY2013Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2013Q3 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
1724000
CY2013Q3 us-gaap Operating Leases Future Minimum Payments Receivable In Four Years
OperatingLeasesFutureMinimumPaymentsReceivableInFourYears
101000
CY2013Q3 us-gaap Assets Current
AssetsCurrent
4007000
CY2013Q3 us-gaap Operating Leases Future Minimum Payments Receivable In Two Years
OperatingLeasesFutureMinimumPaymentsReceivableInTwoYears
386000
CY2013Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
2036000
CY2013Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
15000
CY2013Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
61000
CY2013Q3 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
50000
CY2013Q3 us-gaap Inventory Work In Process
InventoryWorkInProcess
428000
CY2013Q3 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
5000
CY2013Q3 us-gaap Assets
Assets
6927000
CY2013Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1792000
CY2013Q3 us-gaap Inventory Raw Materials
InventoryRawMaterials
141000
CY2013Q3 us-gaap Operating Leases Future Minimum Payments Receivable
OperatingLeasesFutureMinimumPaymentsReceivable
984000
CY2013Q3 us-gaap Finite Lived Patents Gross
FiniteLivedPatentsGross
2531000
CY2013Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
398000
CY2013Q3 us-gaap Inventory Net
InventoryNet
1360000
CY2013Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
61000
CY2013Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
2477000
CY2013Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1983000
CY2013Q3 us-gaap Inventory Gross
InventoryGross
1437000
CY2013Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
407000
CY2013Q3 us-gaap Operating Leases Future Minimum Payments Receivable In Five Years
OperatingLeasesFutureMinimumPaymentsReceivableInFiveYears
3000
CY2013Q3 us-gaap Operating Leases Future Minimum Payments Receivable In Three Years
OperatingLeasesFutureMinimumPaymentsReceivableInThreeYears
397000
CY2013Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
61000
CY2013Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
61000
CY2013Q3 us-gaap Operating Leases Future Minimum Payments Receivable Current
OperatingLeasesFutureMinimumPaymentsReceivableCurrent
97000
CY2013Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
2300000
CY2013Q3 us-gaap Inventory Finished Goods
InventoryFinishedGoods
868000
CY2013Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
851000
CY2013Q3 isco Advances
Advances
250000
CY2013Q3 isco Revaluation Assumptions Capital Raising Minimum Criteria Level
RevaluationAssumptionsCapitalRaisingMinimumCriteriaLevel
0.25
CY2013Q3 isco Deposits And Other Assets
DepositsAndOtherAssets
33000
CY2013Q3 isco Revenue Realized From Agreement
RevenueRealizedFromAgreement
0
CY2013Q3 isco Percentage Of Ownership In Issue And Outstanding Share Of Common Stock Parent Company
PercentageOfOwnershipInIssueAndOutstandingShareOfCommonStockParentCompany
0.937 pure
CY2013Q3 isco Share Based Compensation Arrangement By Share Based Payments Award Non Option Equity Instruments Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentsAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice
0.16
CY2013Q3 isco Warrant Liabilities
WarrantLiabilities
4400000
CY2006Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1350000 shares
CY2006Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000 shares
CY2006Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2006Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2006Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2006Q4 us-gaap Stockholders Equity
StockholdersEquity
4697000
CY2006Q4 isco Stock Issued During Period Shares Issued For Contract To Provide Investor Relations Services
StockIssuedDuringPeriodSharesIssuedForContractToProvideInvestorRelationsServices
1000000 shares
CY2006Q4 isco Stock Issued During Period Shares Issued For Legal Consulting Services
StockIssuedDuringPeriodSharesIssuedForLegalConsultingServices
350000 shares
CY2007Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1370000 shares
CY2007Q4 us-gaap Sale Of Stock Price Per Share
SaleOfStockPricePerShare
1.00
CY2007Q4 us-gaap Stockholders Equity
StockholdersEquity
212000
CY2007Q4 isco Additional Warrants Received Related To Share Transactions
AdditionalWarrantsReceivedRelatedToShareTransactions
274000 shares
CY2008Q4 us-gaap Stockholders Equity
StockholdersEquity
433000
CY2008Q4 isco Revalued Exercise Price Of Warrants Or Rights
RevaluedExercisePriceOfWarrantsOrRights
0.56
CY2009Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
9565552 shares
CY2009Q4 us-gaap Stockholders Equity
StockholdersEquity
-2270000
CY2009Q4 isco Share Based Compensation Arrangement By Share Based Payments Award Non Option Equity Instruments Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentsAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice
0.45
CY2010Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
6670878 shares
CY2010Q4 us-gaap Preferred Stock Shares Subscribed But Unissued Value
PreferredStockSharesSubscribedButUnissuedValue
0
CY2010Q4 us-gaap Stockholders Equity
StockholdersEquity
5389000
CY2010Q4 isco Share Based Compensation Arrangement By Share Based Payments Award Non Option Equity Instruments Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentsAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice
0.45
CY2011Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
6569550 shares
CY2011Q4 us-gaap Common Stock Shares Subscriptions
CommonStockSharesSubscriptions
5000
CY2011Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
38000
CY2011Q4 us-gaap Stockholders Equity
StockholdersEquity
3623000
CY2011Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1337000
CY2011Q4 isco Share Based Compensation Arrangement By Share Based Payments Award Non Option Equity Instruments Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentsAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice
0.49
CY2012Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
87388815 shares
CY2012Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
87388815 shares
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
3500000 shares
CY2012Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000 shares
CY2012Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
969000
CY2012Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
4000
CY2012Q4 us-gaap Liabilities Current
LiabilitiesCurrent
2187000
CY2012Q4 us-gaap Stockholders Equity
StockholdersEquity
-1758000
CY2012Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
5000
CY2012Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-71792000
CY2012Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
233000
CY2012Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
449000
CY2012Q4 us-gaap Common Stock Value
CommonStockValue
87000
CY2012Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
5370000
CY2012Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
36000
CY2012Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2012Q4 us-gaap Assets Current
AssetsCurrent
2582000
CY2012Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1634000
CY2012Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
211000
CY2012Q4 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
5000
CY2012Q4 us-gaap Assets
Assets
5370000
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
654000
CY2012Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
276000
CY2012Q4 us-gaap Finite Lived Patents Gross
FiniteLivedPatentsGross
2083000
CY2012Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
273000
CY2012Q4 us-gaap Inventory Net
InventoryNet
1199000
CY2012Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
2474000
CY2012Q4 us-gaap Inventory Gross
InventoryGross
1235000
CY2012Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
456000
CY2012Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
748000
CY2012Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1134000
CY2012Q4 isco Advances
Advances
250000
CY2012Q4 isco Liabilities Associated With Warrants
LiabilitiesAssociatedWithWarrants
0
CY2012Q4 isco Deposits And Other Assets
DepositsAndOtherAssets
20000
CY2012Q4 isco Share Based Compensation Arrangement By Share Based Payments Award Non Option Equity Instruments Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentsAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice
0.34
CY2013Q1 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
5062500 shares
CY2013Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
10125000 shares
CY2013Q1 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights
0.20
CY2013Q1 us-gaap Common Stock Value
CommonStockValue
2025000
CY2013Q1 isco Percentage Of Shares Purchased After Exercising Warrants
PercentageOfSharesPurchasedAfterExercisingWarrants
0.50 pure
CY2013Q1 isco Stock Issued During Period New Issues Value Per Share
StockIssuedDuringPeriodNewIssuesValuePerShare
0.20
CY2013Q3 isco Number Of Units Issued
NumberOfUnitsIssued
20000000 shares
dei Trading Symbol
TradingSymbol
ISCO
dei Entity Registrant Name
EntityRegistrantName
International Stem Cell CORP
dei Amendment Flag
AmendmentFlag
false
dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2013
dei Document Type
DocumentType
10-Q
dei Document Period End Date
DocumentPeriodEndDate
2013-09-30
dei Entity Central Index Key
EntityCentralIndexKey
0001355790
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
P6Y5M27D
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted
49929166 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
1.1834 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Forfeitures
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures
3300000 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.877 pure
us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Remaining Contractual Term2
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2
P6Y7D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y1M6D
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Method Used
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsMethodUsed
Monte-Carlo simulation method
us-gaap Property Plant And Equipment Useful Life
PropertyPlantAndEquipmentUsefulLife
P5Y
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
114830000 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.00 pure
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-4233000
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.07
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.0095 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised
1700000 shares
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-7712000
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Issues
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues
4635000
us-gaap Payments To Acquire Other Property Plant And Equipment
PaymentsToAcquireOtherPropertyPlantAndEquipment
34000
us-gaap Operating Income Loss
OperatingIncomeLoss
-5609000
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
480000
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-49000
us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-16000
us-gaap Interest Paid
InterestPaid
2000
us-gaap Use Of Estimates
UseOfEstimates
<div> <p style="MARGIN-TOP: 18px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: Times New Roman" size="2"><i>Use of Estimates</i></font></p> <p style="MARGIN-TOP: 6px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: Times New Roman" size="2">The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the amounts reported in the unaudited condensed consolidated financial statements. Significant estimates include patent life (remaining legal life versus remaining useful life), inventory carrying values and transactions using the Black-Scholes option pricing model, e.g., warrants and stock options. Actual results could differ from those estimates.</font></p> </div>
us-gaap Revenue Recognition Deferred Revenue
RevenueRecognitionDeferredRevenue
<div> <p style="MARGIN-TOP: 18px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: Times New Roman" size="2"><i>Deferred Revenue</i></font></p> <p style="MARGIN-TOP: 6px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: Times New Roman" size="2">The Company recognizes revenue from LSC products when persuasive evidence of an arrangement exists, delivery has occurred or services have been rendered, the seller&#x2019;s price to the buyer is fixed or determinable, and collectability is reasonably assured. However, LSC products sold through web-based channels have a 30-day right of return guarantee and therefore, the Company defers all revenue associated with these product sales until the 30-day guarantee has expired. In addition, all costs associated with these product sales are reclassified against the deferred revenue account so that the net deferred revenue balance is presented. At September&#xA0;30, 2013 and December&#xA0;31, 2012, net deferred revenue totaled $156,000 and $233,000, respectively.</font></p> </div>
us-gaap Derivatives Embedded Derivatives
DerivativesEmbeddedDerivatives
<div> <p style="MARGIN-TOP: 18px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: Times New Roman" size="2"><i>Implementation of Accounting Standards Code (ASC) 815-40-15, (formerly known as EITF 07-5 &#x201C;Determining Whether an Instrument (or Embedded Feature) is Indexed to an Entity&#x2019;s Own Stock Price&#x201D;)</i></font></p> <p style="MARGIN-TOP: 6px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: Times New Roman" size="2">The Accounting Standards Code (ASC) 815-40-15, with an effective date of December&#xA0;15, 2008, should have been implemented as of January&#xA0;1, 2009, and in future periods. This Issue applies to any freestanding financial instrument or embedded feature that has all the characteristics of a derivative as described in ASC 815-10-15-83, (previously paragraphs 6&#x2013;9 of Statement 133) for purposes of determining whether that instrument or embedded feature qualifies for the first part of the scope exception in ASC 815-10-74 (previously paragraph 11(a) of Statement 133). This Issue also applies to any freestanding financial instrument that is potentially settled in an entity&#x2019;s own stock, regardless of whether the instrument has all the characteristics of a derivative for purposes of determining whether the instrument is within the scope of ASC 815-40.</font></p> </div>
us-gaap Revenues
Revenues
4412000
us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
180000
us-gaap Stock And Warrants Issued During Period Value Preferred Stock And Warrants
StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants
311000
us-gaap Operating Leases Income Statement Sublease Revenue
OperatingLeasesIncomeStatementSubleaseRevenue
18000
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
4412000
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-7712000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
148000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-2103000
us-gaap Net Income Loss
NetIncomeLoss
-7712000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
201000
us-gaap Payment Of Financing And Stock Issuance Costs
PaymentOfFinancingAndStockIssuanceCosts
646000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1291000
us-gaap Increase Decrease In Deposit Other Assets
IncreaseDecreaseInDepositOtherAssets
13000
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
3285000
us-gaap Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
50000
us-gaap Payments Of Dividends
PaymentsOfDividends
0
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-27000
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
180000
us-gaap Costs And Expenses
CostsAndExpenses
10021000
us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
20000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4461000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
5885000
us-gaap Financial Services Costs
FinancialServicesCosts
738000
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-77000
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
242000
us-gaap Adjustment Of Warrants Granted For Services
AdjustmentOfWarrantsGrantedForServices
0
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
22000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
1138000
us-gaap Marketing Expense
MarketingExpense
1823000
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Sales
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySales
219000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
326000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-447000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
6289000
us-gaap Acquisition Costs
AcquisitionCosts
1730000
us-gaap Cost Of Revenue
CostOfRevenue
1110000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-514000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2627000
us-gaap Increase Decrease In Due To Related Parties Current
IncreaseDecreaseInDueToRelatedPartiesCurrent
11000
us-gaap Asset Impairment Charges
AssetImpairmentCharges
32000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
347000
us-gaap Proceeds From License Fees Received
ProceedsFromLicenseFeesReceived
5000000
us-gaap Depreciation
Depreciation
301000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1300000
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements
27000
us-gaap License Costs
LicenseCosts
340000
isco Warrant Term
WarrantTerm
P5Y
isco Burn Rate Excluding Capital Expenditures And Patent Costs
BurnRateExcludingCapitalExpendituresAndPatentCosts
470000
isco Right Of Return Guarantee Period
RightOfReturnGuaranteePeriod
P30D
isco Patent Costs
PatentCosts
57000
isco Share Based Compensation Arrangements By Share Based Payment Award Non Option Equity Instruments Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodWeightedAverageExercisePrice
0.15
isco Percentage Of Net Profits Generated From Proprietary Mailings
PercentageOfNetProfitsGeneratedFromProprietaryMailings
0.40 pure
isco Percentage Of Net Revenues For Referral Sales
PercentageOfNetRevenuesForReferralSales
0.10 pure
isco Additional Option Fees
AdditionalOptionFees
22500
isco Common Stock Warrants To Be Issued For Benefit Of Third Party Marketing Organization
CommonStockWarrantsToBeIssuedForBenefitOfThirdPartyMarketingOrganization
100000
isco Additional License Fees
AdditionalLicenseFees
400000
isco Share Based Compensation Arrangements By Share Based Payment Award Non Option Equity Instruments Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageExercisePrice
0.16
isco Strike Prices Of Common Stock Warrants Of Tranche Two
StrikePricesOfCommonStockWarrantsOfTrancheTwo
2.00
isco Rent Expense Related To Facility Lease Arrangement
RentExpenseRelatedToFacilityLeaseArrangement
118000
isco Non Cash Compensation Expense
NonCashCompensationExpense
1291000
isco Warrants Issued For Placements Agent Services
WarrantsIssuedForPlacementsAgentServices
115000
isco Strike Prices Of Common Stock Warrants Of Tranche One
StrikePricesOfCommonStockWarrantsOfTrancheOne
1.50
isco Gain Loss Recognized On Revaluation
GainLossRecognizedOnRevaluation
0
isco Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresInPeriodWeightedAverageExercisePrice
0.25
isco Percentage Of Net Revenues For Direct Sales Generated From Proprietary Mailings
PercentageOfNetRevenuesForDirectSalesGeneratedFromProprietaryMailings
0.20 pure
isco Termination Of Agreement
TerminationOfAgreement
P30D
isco Number Of Tranches For Issued Of Common Stock
NumberOfTranchesForIssuedOfCommonStock
2 Tranches
isco Fair Value Of Warrant Liabilities In Excess Of Proceeds
FairValueOfWarrantLiabilitiesInExcessOfProceeds
1390000
isco Change In Inventory Obsolescence
ChangeInInventoryObsolescence
40000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
1.2363 pure
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y8M12D
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
85421000 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.00 pure
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-5119000
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.10
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.0094 pure
us-gaap Revenues
Revenues
3320000
us-gaap Operating Leases Income Statement Sublease Revenue
OperatingLeasesIncomeStatementSubleaseRevenue
7000
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
3320000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-8738000
us-gaap Payments To Acquire Other Property Plant And Equipment
PaymentsToAcquireOtherPropertyPlantAndEquipment
197000
us-gaap Operating Income Loss
OperatingIncomeLoss
-7224000
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
440000
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
19000
us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-50000
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-7234000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
271000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-10000
us-gaap Net Income Loss
NetIncomeLoss
-7234000
us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
237000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-169000
us-gaap Increase Decrease In Deposit Other Assets
IncreaseDecreaseInDepositOtherAssets
4000
us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
4941000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-38000
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
30000
us-gaap Costs And Expenses
CostsAndExpenses
10544000
us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
55000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5364000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
6792000
us-gaap Dividends Preferred Stock
DividendsPreferredStock
129000
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-13000
us-gaap Dividends Preferred Stock Stock
DividendsPreferredStockStock
1375000
us-gaap Adjustment Of Warrants Granted For Services
AdjustmentOfWarrantsGrantedForServices
73000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
1043000
us-gaap Marketing Expense
MarketingExpense
1521000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-287000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
279000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
2088000
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
7000
us-gaap Cost Of Revenue
CostOfRevenue
957000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-630000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2702000
us-gaap Increase Decrease In Due To Related Parties Current
IncreaseDecreaseInDueToRelatedPartiesCurrent
17000
us-gaap Asset Impairment Charges
AssetImpairmentCharges
23000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
369000
us-gaap Depreciation
Depreciation
320000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1800000
isco Revaluation Expenses Recognized
RevaluationExpensesRecognized
38000
isco Reversal Of Preferred Dividends Accreted
ReversalOfPreferredDividendsAccreted
93000
isco Accretion Of Preferred Stock Dividends
AccretionOfPreferredStockDividends
93000
isco Deemed Dividend On Preferred Stock
DeemedDividendOnPreferredStock
1375000
isco Rent Expense Related To Facility Lease Arrangement
RentExpenseRelatedToFacilityLeaseArrangement
86000
isco Non Cash Compensation Expense
NonCashCompensationExpense
1760000
isco Adjustments To Additional Paid In Capital Warrant Issued For Services
AdjustmentsToAdditionalPaidInCapitalWarrantIssuedForServices
-73000
isco Gain Loss Recognized On Revaluation
GainLossRecognizedOnRevaluation
38000
isco Change In Inventory Obsolescence
ChangeInInventoryObsolescence
-23000
CY2013Q1 isco Stock Issued During Period New Issues Value Per Share
StockIssuedDuringPeriodNewIssuesValuePerShare
0.20
CY2013Q3 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
2400000
CY2013Q3 isco Agents Fees Percentage On Gross Proceeds
AgentsFeesPercentageOnGrossProceeds
0.05 pure
CY2013Q3 isco Percentage Of Gross Proceeds Paid To Agent
PercentageOfGrossProceedsPaidToAgent
0.05 pure
CY2006Q4 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
4.42 pure
CY2006Q4 isco Share Exchange Ratio Under Share Exchange Agreement
ShareExchangeRatioUnderShareExchangeAgreement
1 pure
CY2013Q3 isco Issuance Of Common Stock And Warrants Shares
IssuanceOfCommonStockAndWarrantsShares
20000000 shares
CY2013Q3 isco Proceed From Issuance Of Common Stock And Warrants
ProceedFromIssuanceOfCommonStockAndWarrants
2400000
CY2007 isco Investor Relations Services Contract Duration
InvestorRelationsServicesContractDuration
P1Y
CY2006 us-gaap Stockholders Equity Note Stock Split
StockholdersEquityNoteStockSplit
In October 2006, the board of directors of BTHC III approved a stock split of 4.42 shares to 1.
CY2006 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
1350000
CY2006 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
1231000
CY2006 us-gaap Net Income Loss
NetIncomeLoss
-6584000
CY2006 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
842000
CY2006 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
10382000
CY2006 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
-2778000
CY2006 us-gaap Adjustment Of Warrants Granted For Services
AdjustmentOfWarrantsGrantedForServices
638000
CY2006 isco Effect Of Reorganization Transactions In Value
EffectOfReorganizationTransactionsInValue
-606000
CY2006 isco Adjustments To Additional Paid In Capital Warrant Issued For Services
AdjustmentsToAdditionalPaidInCapitalWarrantIssuedForServices
222000
CY2007 us-gaap Stock And Warrants Issued During Period Value Preferred Stock And Warrants
StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants
3000
CY2007 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
169000
CY2007 us-gaap Net Income Loss
NetIncomeLoss
-6072000
CY2009 us-gaap Stock And Warrants Issued During Period Value Preferred Stock And Warrants
StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants
963000
CY2010 isco Warrants Reclassified To Equity
WarrantsReclassifiedToEquity
805000
CY2007 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
427000
CY2007 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
1370000
CY2007 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
-382000
CY2007 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
1157000
CY2007 us-gaap Sale Of Stock Consideration Received On Transaction
SaleOfStockConsiderationReceivedOnTransaction
1200000
CY2009 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
942000
CY2009 us-gaap Net Income Loss
NetIncomeLoss
-8513000
CY2009 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
500000
CY2009 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
410000
CY2009 us-gaap Dividends Preferred Stock Stock
DividendsPreferredStockStock
-364000
CY2009 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
1400000
CY2009 isco Cumulative Effect Adjustment Warrant Liabilities
CumulativeEffectAdjustmentWarrantLiabilities
-1274000
CY2009 isco Adjustments To Additional Paid In Capital Equity Placement Shares
AdjustmentsToAdditionalPaidInCapitalEquityPlacementShares
-250000
CY2009 isco Options Issued For Services
OptionsIssuedForServices
106000
CY2009 isco Stock Issued During Period Value Cashless Exercise Of Warrants
StockIssuedDuringPeriodValueCashlessExerciseOfWarrants
283000
CY2009 isco Adjustments To Additional Paid In Capital Deemed Dividend
AdjustmentsToAdditionalPaidInCapitalDeemedDividend
-869000
CY2009 isco Adjustments To Additional Paid In Capital Warrant Issued For Services
AdjustmentsToAdditionalPaidInCapitalWarrantIssuedForServices
281000
CY2009 isco Stock Issued During Period Value Preferred Stock
StockIssuedDuringPeriodValuePreferredStock
3682000
CY2010 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised
2894674 shares
CY2010 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
1085000
CY2010 us-gaap Stock And Warrants Issued During Period Value Preferred Stock And Warrants
StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants
1493000
CY2010 us-gaap Net Income Loss
NetIncomeLoss
-12723000
CY2010 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
CY2010 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2068000
CY2010 us-gaap Dividends Preferred Stock Stock
DividendsPreferredStockStock
-1037000
CY2010 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
10190000
CY2010 us-gaap Dividends
Dividends
-524000
CY2010 isco Swap Out Of Notes Receivable And Perpetual Preferred Stock
SwapOutOfNotesReceivableAndPerpetualPreferredStock
4763000
CY2010 isco Share Based Compensation Arrangements By Share Based Payment Award Non Option Equity Instruments Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodWeightedAverageExercisePrice
0.47
CY2010 isco Stock Issued During Period Value Cashless Exercise Of Warrants And Options
StockIssuedDuringPeriodValueCashlessExerciseOfWarrantsAndOptions
1538000
CY2010 isco Adjustments To Additional Paid In Capital Warrant Issued For Services
AdjustmentsToAdditionalPaidInCapitalWarrantIssuedForServices
CY2011 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted
200000 shares
CY2011 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised
301328 shares
CY2011 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
303000
CY2011 us-gaap Net Income Loss
NetIncomeLoss
-9171000
CY2011 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3541000
CY2011 us-gaap Dividends Preferred Stock
DividendsPreferredStock
-430000
CY2011 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
3358000
CY2011 isco Stock Issued During Period Value Exercise Of Options And Warrants
StockIssuedDuringPeriodValueExerciseOfOptionsAndWarrants
527000
CY2011 isco Stock Issued During Period Value Cashless Exercise Of Warrants
StockIssuedDuringPeriodValueCashlessExerciseOfWarrants
26000
CY2011 isco Share Based Compensation Arrangement By Share Based Payment Award Vesting Term
ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingTerm
Four quarters
CY2011 isco Share Based Compensation Arrangements By Share Based Payment Award Non Option Equity Instruments Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodWeightedAverageExercisePrice
0.40
CY2011 isco Share Based Compensation Arrangements By Share Based Payment Award Non Option Equity Instruments Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageExercisePrice
1.75
CY2011 isco Adjustments To Additional Paid In Capital Warrant Issued For Services
AdjustmentsToAdditionalPaidInCapitalWarrantIssuedForServices
75000
CY2008 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y
CY2008 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.00 pure
CY2008 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
596000
CY2008 us-gaap Net Income Loss
NetIncomeLoss
-6571000
CY2008 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
735000
CY2008 isco Warrants Issued And Beneficial Conversion Feature
WarrantsIssuedAndBeneficialConversionFeature
911000
CY2008 isco Adjustments To Additional Paid In Capital Deemed Dividend
AdjustmentsToAdditionalPaidInCapitalDeemedDividend
CY2008 isco Stock Issued During Period Value Preferred Stock
StockIssuedDuringPeriodValuePreferredStock
4550000
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Forfeitures
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures
3069550 shares
CY2012 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
59000
CY2012 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
4000
CY2012 us-gaap Net Income Loss
NetIncomeLoss
-9833000
CY2012 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2361000
CY2012 us-gaap Dividends Preferred Stock
DividendsPreferredStock
-222000
CY2012 us-gaap Dividends Preferred Stock Stock
DividendsPreferredStockStock
-1375000
CY2012 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
2084000
CY2012 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements
38000
CY2012 isco Reversal Of Preferred Dividends Accreted
ReversalOfPreferredDividendsAccreted
93000
CY2012 isco Adjustments To Additional Paid In Capital Preferred Stock With Beneficial Conversion Feature
AdjustmentsToAdditionalPaidInCapitalPreferredStockWithBeneficialConversionFeature
1375000
CY2012 isco Adjustments To Additional Paid In Capital Warrant Issued For Services
AdjustmentsToAdditionalPaidInCapitalWarrantIssuedForServices
73000
CY2012 isco Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresInPeriodWeightedAverageExercisePrice
0.66
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-45936000
us-gaap Revenues
Revenues
16745000
us-gaap Repayments Of Other Long Term Debt
RepaymentsOfOtherLongTermDebt
625000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
11000
us-gaap Operating Leases Income Statement Sublease Revenue
OperatingLeasesIncomeStatementSubleaseRevenue
334000
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
16610000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-79934000
us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
94000
us-gaap Payments To Acquire Other Property Plant And Equipment
PaymentsToAcquireOtherPropertyPlantAndEquipment
2720000
us-gaap Operating Income Loss
OperatingIncomeLoss
-64842000
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
2757000
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
407000
us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-96000
us-gaap Interest Paid
InterestPaid
374000
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-70455000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
421000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-5613000
us-gaap Net Income Loss
NetIncomeLoss
-70462000
us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
1320000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
1436000
us-gaap Payment Of Financing And Stock Issuance Costs
PaymentOfFinancingAndStockIssuanceCosts
2406000
us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
500000
us-gaap Increase Decrease In Deposit Other Assets
IncreaseDecreaseInDepositOtherAssets
33000
us-gaap Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
50000
us-gaap License And Services Revenue
LicenseAndServicesRevenue
135000
us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
17202000
us-gaap Related Party Transaction Expenses From Transactions With Related Party
RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
93000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
1330000
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
4536000
us-gaap Costs And Expenses
CostsAndExpenses
81587000
us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
265000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
43589000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
53198000
us-gaap Dividends Preferred Stock
DividendsPreferredStock
8097000
us-gaap Financial Services Costs
FinancialServicesCosts
738000
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
156000
us-gaap Dividends Preferred Stock Stock
DividendsPreferredStockStock
1375000
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
1234000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
26000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
1792000
us-gaap Marketing Expense
MarketingExpense
7762000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
1341000
us-gaap Interest Expense
InterestExpense
2225000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
630000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
35171000
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
7000
us-gaap Cost Of Revenue
CostOfRevenue
5716000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-5470000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
24520000
us-gaap Increase Decrease In Due To Related Parties Current
IncreaseDecreaseInDueToRelatedPartiesCurrent
-149000
us-gaap Asset Impairment Charges
AssetImpairmentCharges
221000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2263000
us-gaap Proceeds From Partnership Contribution
ProceedsFromPartnershipContribution
2685000
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
1081000
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
1360000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
7000
isco Cashless Exercise Of Warrants
CashlessExerciseOfWarrants
1847000
isco Reversal Of Preferred Dividends Accreted
ReversalOfPreferredDividendsAccreted
93000
isco Warrants Issued With Promissory Notes
WarrantsIssuedWithPromissoryNotes
638000
isco Accretion Of Preferred Stock Dividends
AccretionOfPreferredStockDividends
93000
isco Deemed Dividend On Preferred Stock
DeemedDividendOnPreferredStock
8058000
isco Discounts On Convertible Debt From Warrants
DiscountsOnConvertibleDebtFromWarrants
270000
isco Proceeds From Issuance Of Convertible Promissory Notes
ProceedsFromIssuanceOfConvertiblePromissoryNotes
2100000
isco Accretion Of Discount On Bridge Loans
AccretionOfDiscountOnBridgeLoans
638000
isco Payment Of Promissory Notes
PaymentOfPromissoryNotes
2203000
isco Non Cash Compensation Expense
NonCashCompensationExpense
12062000
isco Non Cash Sale Of Preferred Stock
NonCashSaleOfPreferredStock
382000
isco Warrants Issued For Placements Agent Services
WarrantsIssuedForPlacementsAgentServices
1346000
isco Adjustments To Additional Paid In Capital Warrant Issued For Services
AdjustmentsToAdditionalPaidInCapitalWarrantIssuedForServices
-370000
isco Discounts On Convertible Debt From Beneficial Conversion Feature
DiscountsOnConvertibleDebtFromBeneficialConversionFeature
641000
isco Dividend On Preferred Stock Exchange For Note Receivable
DividendOnPreferredStockExchangeForNoteReceivable
95000
isco Interest On Perpetual Preferred Stock Notes Receivable
InterestOnPerpetualPreferredStockNotesReceivable
35000
isco Conversion Of Preferred Stock To Common Stock
ConversionOfPreferredStockToCommonStock
2000
isco Accretion Of Discount On Notes Payable
AccretionOfDiscountOnNotesPayable
103000
isco Fair Value Of Warrant Liabilities In Excess Of Proceeds
FairValueOfWarrantLiabilitiesInExcessOfProceeds
1390000
isco Change In Inventory Obsolescence
ChangeInInventoryObsolescence
76000
CY2012Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
1.2493 pure
CY2012Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y7M6D
CY2012Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
87350000 shares
CY2012Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.00 pure
CY2012Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.02
CY2012Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y4M24D
CY2012Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.0088 pure
CY2012Q3 us-gaap Revenues
Revenues
1187000
CY2012Q3 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
1187000
CY2012Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-1988000
CY2012Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-2080000
CY2012Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-2081000
CY2012Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1000
CY2012Q3 us-gaap Net Income Loss
NetIncomeLoss
-2081000
CY2012Q3 us-gaap Costs And Expenses
CostsAndExpenses
3267000
CY2012Q3 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
1000
CY2012Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1570000
CY2012Q3 us-gaap Dividends Preferred Stock
DividendsPreferredStock
-93000
CY2012Q3 us-gaap Adjustment Of Warrants Granted For Services
AdjustmentOfWarrantsGrantedForServices
36000
CY2012Q3 us-gaap Marketing Expense
MarketingExpense
477000
CY2012Q3 us-gaap Cost Of Revenue
CostOfRevenue
320000
CY2012Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
900000
CY2012Q3 us-gaap Depreciation
Depreciation
106000
CY2012Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
534000.0
CY2012Q3 isco Rent Expense Related To Facility Lease Arrangement
RentExpenseRelatedToFacilityLeaseArrangement
29000
CY2012Q3 isco Gain Loss Recognized On Revaluation
GainLossRecognizedOnRevaluation
0
CY2013Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
0.0000 pure
CY2013Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P0Y
CY2013Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
128243000 shares
CY2013Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.00 pure
CY2013Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.03
CY2013Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P1Y8M12D
CY2013Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.0000 pure
CY2013Q3 us-gaap Revenues
Revenues
1670000
CY2013Q3 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
738000
CY2013Q3 us-gaap Operating Leases Income Statement Sublease Revenue
OperatingLeasesIncomeStatementSubleaseRevenue
5000
CY2013Q3 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
1670000
CY2013Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-3799000
CY2013Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-1703000
CY2013Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-3799000
CY2013Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-2096000
CY2013Q3 us-gaap Net Income Loss
NetIncomeLoss
-3799000
CY2013Q3 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-27000
CY2013Q3 us-gaap Costs And Expenses
CostsAndExpenses
3373000
CY2013Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1362000
CY2013Q3 us-gaap Financial Services Costs
FinancialServicesCosts
738000
CY2013Q3 us-gaap Adjustment Of Warrants Granted For Services
AdjustmentOfWarrantsGrantedForServices
0
CY2013Q3 us-gaap Marketing Expense
MarketingExpense
632000
CY2013Q3 us-gaap Cost Of Revenue
CostOfRevenue
447000
CY2013Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
932000
CY2013Q3 us-gaap Depreciation
Depreciation
100000
CY2013Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
442000.0
CY2013Q3 isco Rent Expense Related To Facility Lease Arrangement
RentExpenseRelatedToFacilityLeaseArrangement
39000
CY2013Q3 isco Gain Loss Recognized On Revaluation
GainLossRecognizedOnRevaluation
0
CY2013Q3 isco Fair Value Of Warrant Liabilities In Excess Of Proceeds
FairValueOfWarrantLiabilitiesInExcessOfProceeds
1390000

Files In Submission

Name View Source Status
0001193125-13-439222-index-headers.html Edgar Link pending
0001193125-13-439222-index.html Edgar Link pending
0001193125-13-439222.txt Edgar Link pending
0001193125-13-439222-xbrl.zip Edgar Link pending
d597913d10q.htm Edgar Link pending
d597913dex311.htm Edgar Link pending
d597913dex312.htm Edgar Link pending
d597913dex321.htm Edgar Link pending
d597913dex322.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
isco-20130930.xml Edgar Link completed
isco-20130930.xsd Edgar Link pending
isco-20130930_cal.xml Edgar Link unprocessable
isco-20130930_def.xml Edgar Link unprocessable
isco-20130930_lab.xml Edgar Link unprocessable
isco-20130930_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending